Patent · US Active

Heterocyclic compounds and uses thereof

US9056877B2 · kind B2 · utility

24Cited by

177References

32Claims

0Family size

Assignee

Infinity Pharmaceuticals, Inc. · US

Inventors

Alfredo C. Castro · Woburn, US
Catherine A. Evans · Somerville, US
Andre Lescarbeau · Somerville, US
Tao Liu · Shanghai, CN
Daniel A. Snyder · Somerville, US
Martin Tremblay · Waltham, US
Pingda Ren · San Diego, US
Yi Liu · San Diego, US
Liansheng Li · San Diego, US
Katrina Chan · Fremont, US

Key dates

Filing date	Jul 18, 2012
Grant date	Jun 16, 2015
Priority date	—
Expiry date	Aug 28, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.